MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses
Citations Over TimeTop 10% of 2020 papers
Abstract
Recent outbreaks of Ebola virus (EBOV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have exposed our limited therapeutic options for such diseases and our poor understanding of the cellular mechanisms that block viral infections. Using a transposon-mediated gene-activation screen in human cells, we identify that the major histocompatibility complex (MHC) class II transactivator (CIITA) has antiviral activity against EBOV. CIITA induces resistance by activating expression of the p41 isoform of invariant chain CD74, which inhibits viral entry by blocking cathepsin-mediated processing of the Ebola glycoprotein. We further show that CD74 p41 can block the endosomal entry pathway of coronaviruses, including SARS-CoV-2. These data therefore implicate CIITA and CD74 in host defense against a range of viruses, and they identify an additional function of these proteins beyond their canonical roles in antigen presentation.
Related Papers
- → Mice Lacking the MHC Class II Transactivator (CIITA) Show Tissue-Specific Impairment of MHC Class II Expression(1996)353 cited
- → The RFX Complex Is Crucial for the Constitutive and CIITA-Mediated Transactivation of MHC Class I and β2-Microglobulin Genes(1998)114 cited
- → CIITA activates the expression of MHC class II genes in mouse T cells(1995)75 cited
- → CpG DNA Induces a Class II Transactivator-Independent Increase in Class II MHC by Stabilizing Class II MHC mRNA in B Lymphocytes(2003)19 cited
- → Tu1870 IL-27 Activates MHC Class II Expression in Intestinal Epithelial Cells via STAT1-Dependent Class II Transactivator (CIITA) Induction(2012)